In addition, manipulation of lipid rafts in effector cells by secreted SM may also explain the selective killing of TNBC, but not ER+ or normal breast epithelial cells, as breast cancer cells with different receptor status have been found to have different lipid raft compositions30, and so, might respond differently to secreted SM. The gene discussed is ESR1; the disease is breast cancer.